We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.36B
AUM Growth
-$421M
Cap. Flow
-$494M
Cap. Flow %
-36.22%
Top 10 Hldgs %
24.41%
Holding
4,677
New
965
Increased
1,296
Reduced
1,507
Closed
833

Sector Composition

Rank Sector Weight
1 Industrials 7.55%
2 Technology 7.19%
3 Financials 6.96%
4 Healthcare 6.81%
5 Consumer Discretionary 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTBL
3351
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$3K ﹤0.01%
52
+38
+271% +$2.41K
ORGS
3352
DELISTED
Orgenesis Inc. Common Stock
ORGS
$3K ﹤0.01%
+53
New +$3.59K
CACG
3353
DELISTED
Legg Mason ETF Investment Trust ClearBridge All Cap Growth ESG ETF
CACG
$3K ﹤0.01%
94
+76
+422% +$2.36K
CMLS
3354
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$3K ﹤0.01%
+180
New +$3.29K
AEL
3355
DELISTED
American Equity Investment Life Holding Company
AEL
$3K ﹤0.01%
+84
New +$3.03K
SIEN
3356
DELISTED
Sientra, Inc.
SIEN
$3K ﹤0.01%
+11
New +$2.42K
CHS
3357
DELISTED
Chicos FAS, Inc.
CHS
$3K ﹤0.01%
312
-713
-70% -$6.34K
AVID
3358
DELISTED
Avid Technology Inc
AVID
$3K ﹤0.01%
486
-244
-33% -$1.36K
SIRE
3359
DELISTED
Sisecam Resources LP
SIRE
$3K ﹤0.01%
105
-388
-79% -$10.6K
ATCO
3360
DELISTED
Atlas Corp.
ATCO
$3K ﹤0.01%
+415
New +$3.73K
NTUS
3361
DELISTED
Natus Medical Inc
NTUS
$3K ﹤0.01%
86
-5,046
-98% -$178K
HSTO
3362
DELISTED
Histogen Inc. Common Stock
HSTO
$3K ﹤0.01%
3
-27
-90% -$24.9K
ZIXI
3363
DELISTED
Zix Corporation
ZIXI
$3K ﹤0.01%
+604
New +$3.35K
TRIL
3364
DELISTED
Trillium Therapeutics Inc.
TRIL
$3K ﹤0.01%
547
+59
+12% +$333
QADB
3365
DELISTED
QAD Inc. Class B
QADB
$3K ﹤0.01%
61
-1,024
-94% -$44.3K
SVBI
3366
DELISTED
Severn Bancorp Inc/MD
SVBI
$3K ﹤0.01%
+300
New +$2.68K
EXFO
3367
DELISTED
EXFO INC.
EXFO
$3K ﹤0.01%
+900
New +$3.47K
AMRB
3368
DELISTED
American River Bankshares
AMRB
$3K ﹤0.01%
196
+161
+460% +$2.52K
DFVS
3369
DELISTED
iPath US Treasury 5-year Bear ETN
DFVS
$3K ﹤0.01%
81
CRHM
3370
DELISTED
CRH Medical Corporation
CRHM
$3K ﹤0.01%
771
-129
-14% -$475
CEL
3371
DELISTED
Cellcom Israel, Ltd.
CEL
$3K ﹤0.01%
371
-450
-55% -$2.67K
PE
3372
DELISTED
PARSLEY ENERGY INC
PE
$3K ﹤0.01%
100
-1,683
-94% -$50K
NE
3373
DELISTED
Noble Corporation
NE
$3K ﹤0.01%
385
-7,964
-95% -$48.3K
IBKC
3374
DELISTED
IBERIABANK Corp
IBKC
$3K ﹤0.01%
+39
New +$3.24K
GPAQU
3375
DELISTED
Gordon Pointe Acquisition Corp. Unit
GPAQU
$3K ﹤0.01%
300
+200
+200% +$2.08K

Similar funds

Tower Research Capital (TRC)'s Q3 2018 Portfolio in Review

As of Q3 2018, Tower Research Capital (TRC) held 4,677 positions worth $1.36B, down 24% from $1.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) withdrew a net $494M in Q3 2018, closing 833 positions and reducing 1,507 holdings. Its most notable exit was NVIDIA, an estimated $6.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 7.5% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.3M.

  • Tower Research Capital (TRC)'s largest Q3 2018 buy was Vanguard S&P 500 ETF: 53,562 shares worth $14.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $151M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2018 reduction was Apple, cutting an estimated $48.1M.
  • Tower Research Capital (TRC) fully exited NVIDIA in Q3 2018, selling an estimated $6.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.36B portfolio in Q3 2018.
  • Tower Research Capital (TRC) opened 965 new positions and closed 833 in Q3 2018.
  • Tower Research Capital (TRC)'s portfolio value fell 24% quarter-over-quarter to $1.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2018, filed 13 Nov 2018.